Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H.P. Acthar Gel for Refractory Cutaneous Dermatomyositis
NCT02245841Phase 4Completed
- Sponsor
- Cleveland Clinic
- Start
- Jun 2015
- Primary completion
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in dermatomyositis (DM), juvenile dermatomyositis (JDM), amyopathic dermatomyositis (ADM), sponsored by Cleveland Clinic. Started Jun 2015; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
dermatomyositis (DM)juvenile dermatomyositis (JDM)amyopathic dermatomyositis (ADM)
Beyond the preview
Go deeper on NCT02245841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02245841.